HUMANITAS MIRASOLE SPA - Italy 

Ranking results:

Past rankings:

2020
Criterium:Position:
Overall Score:> 1000
Total Project Funding per Partner:> 1000
Total Number of Projects:> 1000
2019
Criterium:Position:
Overall Score:900-1000
Total Project Funding per Partner:> 1000
Total Number of Projects:800-900
2018
Criterium:Position:
Overall Score:500-600
Total Project Funding per Partner:900-1000
Total Number of Projects:> 1000
Networking Rank (Reputation):300-400
2016
Criterium:Position:
Overall Score:> 1000
Networking Rank (Reputation):> 1000
2015
Criterium:Position:
Overall Score:700-800
Total Project Funding per Partner:200-300
Total Number of Projects:700-800
Networking Rank (Reputation):> 1000
Partner Constancy:600-700
Project Leadership Index:700-800
2012
Criterium:Position:
Overall Score:900-1000
Total Project Funding per Partner:400-500
Total Number of Projects:69
Total Project Funding:> 1000
Networking Rank (Reputation):900-1000
Partner Constancy:46
Project Leadership Index:75
Diversity Index:60
2011
Criterium:Position:
Overall Score:> 1000
Total Project Funding per Partner:> 1000
Total Number of Projects:> 1000
Total Project Funding:> 1000
Partner Constancy:> 1000
Project Leadership Index:> 1000
Diversity Index:> 1000
2010
Criterium:Position:
Overall Score:> 1000
Total Project Funding per Partner:> 1000
Total Number of Projects:> 1000
Total Project Funding:> 1000
Networking Rank (Reputation):> 1000
Partner Constancy:> 1000
Project Leadership Index:> 1000
Diversity Index:> 1000
2009
Criterium:Position:
Overall Score:> 1000
Total Project Funding per Partner:300-400
Total Number of Projects:900-1000
Total Project Funding:> 1000
Networking Rank (Reputation):> 1000
Partner Constancy:> 1000
Project Leadership Index:> 1000
Diversity Index:> 1000
2008
Criterium:Position:
Overall Score:> 1000
Total Project Funding per Partner:> 1000
Total Number of Projects:> 1000
Total Project Funding:> 1000
Networking Rank (Reputation):> 1000
Partner Constancy:> 1000
Project Leadership Index:> 1000
Diversity Index:> 1000
2007
Criterium:Position:
Overall Score:> 1000
Total Project Funding per Partner:> 1000
Total Number of Projects:> 1000
Total Project Funding:> 1000
Partner Constancy:> 1000
Project Leadership Index:> 1000
Diversity Index:> 1000

Ranking timeline:

Project Participation Performance(2010-01-01 - 2025-12-31 ):

Total Project Funding:

Total funding allocated to projects this organisation participated or coordinated

Funding per Partner:

Since 2014 individual funding per partner. If data is not available at CORDIS: total funding / No of participants.

Projects:

Leadership:

Total number of projects: 28
As coordinator: 2
As participant: 15
Sole participant: 11
Coordinator / Participant Ratio: 0.13*

*Ratio includes only projects with > 2 partners

Summary:

Total project funding [€]:Projects [No]:
Year:coordinator*participant*per partner  as coordinatoras participant
2022 0 15.116.876 685.000 2
2021 0 22.498.375 903.125 3
2020 183.473 22.703.363 732.098 1 2
2019 339.750 6.844.802 1.312.750 2 2
2018 5.596.928 2.000.000 1.651.995 1 1
2017 168.277 0 168.277 1
2016 0 3.895.551 516.123 1
2015 1.668.277 8.477.516 4.615.358 2 2
2014 187.415 0 187.415 1
2013 0 2.350.342 343.720 1
2012 2.600.000 0 2.600.000 2
2011 200.000 10.959.000 169.333 2 1
2010 100.000 0 100.000 1
*n.b.: These numbers represent the total amount of funds allocated to projects this institution has participated in, not the funding allocated to this institution

Networking:

Partners:

Institution:Projects [No]:
AUSTRALO INTERINNOV MARKETING LAB SL3
CHARITE UNIVERSITAETSMEDIZIN BERLIN3
UNIVERSIDAD POLITECNICA DE MADRID3
UNIVERSITA DEGLI STUDI DI PADOVA3
UNIVERSITAIR MEDISCH CENTRUM UTRECHT3
UNIVERSITY OF BOLOGNA3
ASSISTANCE PUBLIQUE HOPITAUX DE PARIS2
DATAWIZARD2
FOUNDATION FOR RESEARCH AND TECHNOLOGY HELLAS2
FUNDACIO HOSPITAL UNIVERSITARI VALL D'HEBRON INSTITUT DE RECERCA2
HUMANITAS UNIVERSITY2
INTRASOFT INTERNATIONAL2
ISOFT SANIDAD2
ISTITUTO SUPERIORE DI SANITA2
KAROLINSKA INSTITUTE2
KATHOLIEKE UNIVERSITEIT LEUVEN2
KING'S COLLEGE LONDON2
MOTOR NEURONE DISEASE ASSOCIATION2
QUEEN MARY AND WESTFIELD COLLEGE UNIVERSITY OF LONDON2
TECHNISCHE UNIVERSITAET MUENCHEN2
THE EUROPEAN INSTITUTE FOR INNOVATION THROUGH HEALTH DATA2
THE UNIVERSITY OF SHEFFIELD2
AARHUS KOMMUNEHOSPITAL AARHUS UNIVERSITY HOSPITAL1
ACADEMIC MEDICAL CENTRE AMSTERDAM1
ACADEMISCH MEDISCH CENTRUM BIJ DE UNIVERSITEIT VAN AMSTERDAM1
ACCELERO BIOANALYTICS1
AGENCY FOR SUSTAINABLE DEVELOPMENT AND EUROINTEGRATION ECOREGIONS1
ALGAIA1
ALPHA CONSULTANTS1
AMC MEDICAL RESEARCH BV1
ASSIMILA LIMITED1
ASSOCIACAO OCEANO VERDE LABORATORIO COLABORATIVO PARA O DESENVOLVIMENTO DE TECNOLOGIAS E PRODUTOS VERDES DO OCEANO1
ASSOCIATION GENETHON1
AT4 WIRELESS1
AUSTRIAN RESEARCH CENTERS SIEBERDORF1
BIOMERIEUX1
BOSONIT SOCIEDAD LIMITADA1
BRUSCHETTINI1
CENTRE DE REGULACIO GENOMICA1
CENTRE HOSPITALIER REGIONAL UNIVERSITAIRE DE TOURS1
CENTRE HOSPITALIER REGIONAL UNIVERSITAIRE NANCY1
CENTRE HOSPITALIER UNIVERSITAIRE1
CENTRE HOSPITALIER UNIVERSITAIRE VAUDOIS1
CENTRO DE CIENCIAS DO MAR DO ALGARVE1
CHAMBRE DE COMMERCE ET D'INDUSTRIE DE REGION PARIS ILEDEFRANCE1
CHRISTIAN ALBRECHTS UNIVERSITAET ZU KIEL1
COMMISSARIAT A L'ENERGIE ATOMIQUE1
COMMUNE D'IXELLES1
COMUNE DI MILANO1
CONSORZIO INTERUNIVERSITARIO PER LA GESTIONE DEL CENTRO DI CALCOLO ELETTRONICO DELL'ITALIA NORD ORIENTALE1
CREOTECH INSTRUMENTS SPOLKA AKCYJNA1
CSEM CENTRE SUISSE D'ELECTRONIQUE ET DE MICROTECHNIQUE SA RECHERCHE ET DEVELOPPEMENT1
DAMAN P/S1
DATAREADY LIMITED1
DESCIN BV1
DH HEALTHCARE PROVIDER SOFTWARE SPAIN SLU1
DIAKONHJEMMET SYKEHUS AS1
DIMOS PEIRAIA1
DXC TECHNOLOGY SERVICIOS ESPANA SL1
EHT TECHNOLOGIES1
EIGHT BELLS1
ELI LILLY AND COMPANY1
ELOOP1
ENABLINGMNT1
ENCO1
ENTERPRISE SOLUTIONS CONSULTORIA Y APLICACIONES1
EREVNITIKO PANEPISTIMIAKO INSTITOUTO SYSTIMATON EPIKOINONION KAI YPOLGISTONEMP1
ETHNIKO KAI KAPODISTRIAKO PANEPISTIMIO ATHINON1
EURICE EUROPEAN RESEARCH AND PROJECT OFFICE1
EURONET CONSULTING1
EUROPEAN ALLIANCE OF ASSOCIATIONS FOR RHEUMATOLOGY1
EUROPEAN ASSOCIATION OF REMOTE SENSING COMPANIES1
EUROPEAN FEDERATION OF ASTHMA &ALLERGY ASSOCIATIONS IDEELL FORENING1
EUROPEAN FEDERATION OF CROHN'S AND ULCERATIVE COLITIS ASSOCIATIONS1
EUROPEAN SCIENCE COMMUNICATION INSTITUTE GGMBH1
EUTEMA RESEARCH SERVICES1
F6S NETWORK IRELAND LIMITED1
F6S NETWORK LIMITED1
FINNISH METEOROLOGICAL INSTITUTE1
FONDAZIONE ISTITUTO ITALIANO DI TECNOLOGIA1
FONDAZIONE MULTIMEDICA ONLUS1
FORUM DES PATIENTS EUROPEENS1
FRAUNHOFER GESELLSCHAFT ZUR FOERDERUNG DER ANGEWANDTEN FORSCHUNG E V1
FUNDACION CENTRO DE TECNOLOGIAS DE INTERACCION VISUAL Y COMUNICACIONES VICOMTECH1
FUNDACION PARA LA INVESTIGACION BIOMEDICA DEL HOSPITAL UNIVERSITARIO CLINICO SAN CARLOS1
GEOSYSTEMS HELLAS IT KAI EFARMOGESGEOPLIROFORIAKON SYSTIMATON ANONIMIETAIREIA1
GERENCIA REGIONAL DE SALUD DE CASTILLA Y LEON1
GLAXOSMITHKLINE RESEARCH AND DEVELOPMENT1
GLSMED LEARNING HEALTH1
GOETEBORGS UNIVERSITET1
GOPSIS LDA1
HARTERAAD1
ICON CLINICAL RESEARCH LIMITED1
INFORMATION TECHNOLOGY FOR TRANSLATIONAL MEDICINE1
INSERM TRANSFERT1
INSTITUT EUROPEEN D ADMINISTRATION DES AFFAIRES1
INSTITUT FUER MIKROTECHNIK MAINZ1
INSTITUTE OF MICROBIOLOGY ACADEMY OF SCIENCES OF THE CZECH REPUBLIC1
INSTITUTO DE SALUD MUSCULOESQUELETICA SL1
IRCCS AZIENDA OSPEDALIERO UNIVERSITARIA DI BOLOGNA1

Constancy:

Total number of partners: 203
Partner loyalty:
Frequent Partner: (> 2 projects): 18
Rare Partner: 185
Frequent / Rare Partner Ratio: 0.1

Project overview:

Start dateProjectacronymrolefundingpartners
2022-12-01Synthetic generation of hematological data over federated computing frameworks SYNTHEMAparticipant6.514.56016
2022-12-01Maximising Impact of Prescription Drugs in Rheumatoid Arthritis SQUEEZEparticipant8.602.31613
2021-06-01ALGAE4IBD –FROM NATURE TO BEDSIDE- ALGAE BASED BIO COMPOUND FOR PREVENTION AND TREATMENT OF INFLAMMATION, PAIN AND IBD Algae4IBDparticipant7.499.51724
2021-06-01Development of a Support System for Improved Resilience and Sustainable Urban areas to cope with Climate Change and Extreme Events based on GEOSS and Advanced Modelling Tools HARMONIAparticipant4.999.79423
2021-01-01Genomics and Personalized Medicine for all though Artificial Intelligence in Haematological Diseases GenoMed4ALLparticipant9.999.06428
2020-11-01COVID eXponential Programme COVID-Xparticipant7.203.36312
2020-03-16Identification and functional validation of novel enhancer sequences involved in pituitary gland development and pathology Pituitary enhancerscoordinator183.4731
2020-01-01Better control and treatment of immune-mediated diseases by exploring the universe of microenvironment imposed tissue signatures and their correlates in liquid biopsies ImmUniverseparticipant15.500.00028
2019-07-16Role of the Maternal Gut Microbiota in Immune Activation at the Maternal-Foetal Interface: Impact on Preeclampsia and Offspring's Immune Development DaPhNIscoordinator168.2771
2019-06-01Physiological consequences of Protocadherin-10 sumoylation on neuronal function. SUMO-PCDH10coordinator171.4731
2019-06-01TRAIN-HEART TRAIN-HEARTparticipant3.940.38916
2019-05-01Light and Organic Nanotechnology for Cardiovascular Disease LION-HEARTEDparticipant2.904.4148
2018-07-01Direct cell reprogramming therapy in myocardial regeneration through an engineered multifunctional platform integrating biochemical instructive cues BIORECARparticipant2.000.0002
2018-01-01Safety and efficacy of tauroursodeoxycholic acid (TUDCA) as add-on treatment in patients affected by amyotrophic lateral sclerosis (ALS) TUDCA-ALScoordinator5.596.92810
2017-01-01In vivo engineering of monocytes loaded with nano-chemotherapeutic formulations: a novel live-cell mediated drug delivery system for the treatment of cancer MONONANOCHEMcoordinator168.2771
2016-03-01European Sepsis Academy: towards new biomarkers to improve sepsis management ESA -ITNparticipant3.895.5518
2015-09-01Generation and maintenance of long-lived memory T cells in humans PERSYSTcoordinator1.500.0001
2015-09-01Efficacy and safety of low-dose IL-2 (ld-IL-2) as a Treg enhancer for anti-neuroinflammatory therapy in newly diagnosed Amyotrophic Lateral Sclerosis (ALS) patients MIROCALSparticipant5.980.43512
2015-09-01PTX3 in Humoral Innate Immunity PHIIparticipant2.497.0811
2015-05-20Development and Evaluation of Nanomedicines for Cancer Treatment through Immunomodulation: Targeting Tumor-Associated Macrophages NANOTAMcoordinator168.2771
2014-04-01mRNA translational regulation in heart failure MRNA IN HEARTcoordinator187.4151
2013-04-01Signalling compartmentalization and vesicle Trafficking at the Phagocytic Synapses STEPSparticipant2.350.3422
2012-10-01Epigenetics and microRNAs in Myocardial Function and Disease CARDIOEPIGENcoordinator2.500.0001
2012-08-01Improving adoptive T cell transfer immunotherapy for cancer with T memory stem cells STEMIMMUNEcoordinator100.0001
2011-10-01ICT-enabled, cellular artificial liver system incorporating personalized patient management and support d-LIVERparticipant10.959.00015
2011-08-01Role of microRNAs 143 and 145 in cardiovascular physiology and disease: from bench to bedside From Bench to Bedsidcoordinator100.0002
2011-02-01Characterization of NK cell distributions and functions in human tissues in HIV-1 pathogenesis CNKHIVcoordinator100.0001
2010-08-01Global microRNA profiling of normal and Pbx1-null hematopoietic stem cells and progenitors for the identification of new regulators of the balance between self-renewal and differentiation HSC self-renewalcoordinator100.0001

Alias institution names:

  • HUMANITAS MIRASOLE